West Pharmaceutical Services, Inc. (NYSE:WST), a global company involved in innovative solutions for injectable drug administration, announced on Friday that it has received approval from its board of directors for its second-quarter 2023 dividend.
The company has approved a second quarter dividend of USD0.19 per share.
The dividend will be paid to shareholders of record at 26 April 2023 on 3 May 2023.
Roquefort Therapeutics advances novel siRNA therapeutics
Perrigo Company announces quarterly dividend
Amgen announces Q3 2023 dividend
McKesson Corporation boosts quarterly dividend by 15% to USD0.62 per share